ProfileGDS4718 / 225471_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 78% 75% 80% 78% 74% 80% 73% 77% 78% 77% 74% 74% 77% 78% 81% 73% 73% 76% 77% 72% 77% 77% 75% 75% 74% 79% 76% 72% 75% 80% 76% 83% 77% 76% 74% 74% 75% 76% 77% 81% 76% 77% 74% 79% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.6002978
GSM549102patient 115, normal, homogenized [OPG study]7.307575
GSM549104patient 119, normal, homogenized [OPG study]7.969880
GSM549108patient 138, normal, homogenized [OPG study]7.5311478
GSM549119patient 077, normal, homogenized [OPG study]7.1391174
GSM549133patient 032, cancer, homogenized [OPG study]7.9744580
GSM549139patient 042, cancer, homogenized [OPG study]7.1863273
GSM549099patient 107, normal, homogenized [OPG study]7.4921377
GSM549109patient 139, normal, homogenized [OPG study]7.6250978
GSM549110patient 046, normal, homogenized [OPG study]7.470877
GSM549114patient 063, normal, homogenized [OPG study]7.2543774
GSM549122patient 082, normal, homogenized [OPG study]7.1961674
GSM549134patient 033, cancer, homogenized [OPG study]7.5548277
GSM549136patient 036, cancer, homogenized [OPG study]7.6830578
GSM549140patient 044, cancer, homogenized [OPG study]8.1062381
GSM549111patient 047, normal, homogenized [OPG study]7.1958173
GSM549113patient 057, normal, homogenized [OPG study]7.1859873
GSM549132patient 031, cancer, homogenized [OPG study]7.4780576
GSM549137patient 038, cancer, homogenized [OPG study]7.5601177
GSM549142patient 047, cancer, homogenized [OPG study]6.9650372
GSM549100patient 110, normal, homogenized [OPG study]7.4129877
GSM549107patient 135, normal, homogenized [OPG study]7.5300477
GSM549115patient 068, normal, homogenized [OPG study]7.3892175
GSM549116patient 072, normal, homogenized [OPG study]7.3230675
GSM549120patient 078, normal, homogenized [OPG study]7.226574
GSM549131patient 030, cancer, homogenized [OPG study]7.9130579
GSM549118patient 074, normal, homogenized [OPG study]7.4821276
GSM549129patient 027, cancer, homogenized [OPG study]7.152672
GSM549123patient 088, normal, homogenized [OPG study]7.3252475
GSM549124patient 006, cancer, homogenized [OPG study]7.7954480
GSM549126patient 015, cancer, homogenized [OPG study]7.4516476
GSM549128patient 025, cancer, homogenized [OPG study]8.2490883
GSM549103patient 117, normal, homogenized [OPG study]7.375777
GSM549117patient 073, normal, homogenized [OPG study]7.4506276
GSM549138patient 041, cancer, homogenized [OPG study]7.3229374
GSM549141patient 045, cancer, homogenized [OPG study]7.3240174
GSM549130patient 028, cancer, homogenized [OPG study]7.3394975
GSM549101patient 111, normal, homogenized [OPG study]7.4378776
GSM549105patient 128, normal, homogenized [OPG study]7.4734977
GSM549106patient 134, normal, homogenized [OPG study]8.1802581
GSM549112patient 048, normal, homogenized [OPG study]7.4162476
GSM549125patient 011, cancer, homogenized [OPG study]7.4607777
GSM549127patient 024, cancer, homogenized [OPG study]7.3586174
GSM549135patient 035, cancer, homogenized [OPG study]7.8840879